Cannabidiol Adverse Effects and Toxicity.

Abstract:

BACKGROUND:Currently, there is a great interest in the potential medical use of cannabidiol (CBD), a non-intoxicating cannabinoid. Productive pharmacological research on CBD occurred in the 1970s and intensified recently with many discoveries about the endocannabinoid system. Multiple preclinical and clinical studies led to FDA-approval of Epidiolex®, a purified CBD medicine formulated for oral administration for the treatment of infantile refractory epileptic syndromes, by the US Food and Drug Administration in 2018. The World Health Organization considers rescheduling cannabis and cannabinoids. CBD use around the world is expanding for diseases that lack scientific evidence of the drug's efficacy. Preclinical and clinical studies also report adverse effects (AEs) and toxicity following CBD intake. METHODS:Relevant studies reporting CBD's AEs or toxicity were identified from PubMed, Cochrane Central, and EMBASE through January 2019. Studies defining CBD's beneficial effects were included to provide balance in estimating risk/benefit. RESULTS:CBD is not risk-free. In animals, CBD AEs included developmental toxicity, embryo-fetal mortality, central nervous system inhibition and neurotoxicity, hepatocellular injuries, spermatogenesis reduction, organ weight alterations, male reproductive system alterations, and hypotension, although at doses higher than recommended for human pharmacotherapies. Human CBD studies for epilepsy and psychiatric disorders reported CBD-induced drug-drug interactions, hepatic abnormalities, diarrhea, fatigue, vomiting, and somnolence. CONCLUSION:CBD has proven therapeutic efficacy for serious conditions such as Dravet and Lennox-Gastaut syndromes and is likely to be recommended off label by physicians for other conditions. However, AEs and potential drug-drug interactions must be taken into consideration by clinicians prior to recommending off-label CBD.

journal_name

Curr Neuropharmacol

authors

Huestis MA,Solimini R,Pichini S,Pacifici R,Carlier J,Busardò FP

doi

10.2174/1570159X17666190603171901

subject

Has Abstract

pub_date

2019-01-01 00:00:00

pages

974-989

issue

10

eissn

1570-159X

issn

1875-6190

pii

CN-EPUB-98720

journal_volume

17

pub_type

杂志文章,评审
  • Mesenchymal stem cells for treatment of CNS injury.

    abstract::Brain and spinal cord injuries present significant therapeutic challenges. The treatments available for these conditions are largely ineffective, partly due to limitations in directly targeting the therapeutic agents to sites of pathology within the central nervous system (CNS). The use of stem cells to treat these co...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015910793358204

    authors: Azari MF,Mathias L,Ozturk E,Cram DS,Boyd RL,Petratos S

    更新日期:2010-12-01 00:00:00

  • Modelling anxiety in humans for drug development.

    abstract::Animal behavioural profiles are commonly employed to investigate new therapeutic agents to treat anxiety disorders as well as to investigate the mechanism of action of anxiolytic drugs. However, many clinically important symptoms of anxiety can not be modelled directly in animals. Human models of anxiety should bridge...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015907780077114

    authors: Siepmann M,Joraschky P

    更新日期:2007-03-01 00:00:00

  • Recent Advances in Pathophysiology of Traumatic Brain Injury.

    abstract:BACKGROUND:Traumatic brain injury (TBI) constitutes the primary reason for mortality and morbidity in persons worldwide below 45 years of age. 1.7 million Traumatic events occur yearly in the United States alone, considering for 50,000 deaths. In severe traumatic brain injury sufferers, a considerable achievement attai...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159X15666170613083606

    authors: Kaur P,Sharma S

    更新日期:2018-01-01 00:00:00

  • Impaired spatial memory after ketamine administration in chronic low doses.

    abstract::Ketamine is a noncompetitive antagonist of the NMDA-receptors, used as a dissociative anesthetic, presently included in the category of the psychoactive substances known as "club drugs". Ketamine administration was associated with impaired working memory and increased psychopathological symptoms, but there is a lack o...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015911795016912

    authors: Venâncio C,Magalhães A,Antunes L,Summavielle T

    更新日期:2011-03-01 00:00:00

  • Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage.

    abstract::Alzheimer's disease, Parkinson's disease, traumatic brain and spinal cord injury and neuroinflammatory multiple sclerosis are diverse disorders of the central nervous system. However, they are all characterized by various levels of inappropriate inflammatory/immune response along with tissue destruction. In the gastro...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x14666160121115210

    authors: Földes A,Kádár K,Kerémi B,Zsembery Á,Gyires K,S Zádori Z,Varga G

    更新日期:2016-01-01 00:00:00

  • Traumatic Brain Injury: A Forensic Approach: A Literature Review.

    abstract::Traumatic brain injury (TBI) is the principal cause of invalidity and death in the population under 45 years of age worldwide. This mini-review aims to systematize the forensic approach in neuropathological studies, highlighting the proper elements to be noted during external, radiological, autoptical, and histologica...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X17666191101123145

    authors: Bertozzi G,Maglietta F,Sessa F,Scoto E,Cipolloni L,Di Mizio G,Salerno M,Pomara C

    更新日期:2020-01-01 00:00:00

  • Current experimental therapy for Alzheimer's disease.

    abstract::In the past decade, enormous efforts have been devoted to understand the genetics and molecular pathogenesis of Alzheimer's disease (AD), which has been transferred into extensive experimental approaches aimed at reversing disease progression. The trend in future AD therapy has been shifted from traditional anti-acety...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015907780866901

    authors: Chen S,Zhang XJ,Li L,Le WD

    更新日期:2007-01-01 00:00:00

  • Clearing the brain's cobwebs: the role of autophagy in neuroprotection.

    abstract::Protein aggregates or inclusion bodies are common hallmarks of age-related neurodegenerative disorders. Why these aggregates form remains unclear. Equally debated is whether they are toxic, protective, or simple by-products. Increasing evidence, however, supports the notion that in general aggregates confer toxicity a...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015908784533897

    authors: Bossy B,Perkins G,Bossy-Wetzel E

    更新日期:2008-06-01 00:00:00

  • Pharmacological strategy for congenital myasthenic syndrome with CHRNE mutations: a meta-analysis of case reports.

    abstract:BACKGROUND:Congenital myasthenic syndromes (CMSs) are a heterogeneous group of neuromuscular disorders. Mutations of the nicotinic acetylcholine receptor epsilon subunit gene (CHRNE) are the most common causes of these disorders. CMSs are gaining increasing recognition by clinicians. However, pharmacological treatment ...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X18666200729092332

    authors: Huang K,Luo YB,Bi FF,Yang H

    更新日期:2020-07-28 00:00:00

  • Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson's Disease.

    abstract::Autophagy is a cellular quality control mechanism crucial for neuronal homeostasis. Defects in autophagy are critically associated with mechanisms underlying Parkinson's disease (PD), a common and debilitating neurodegenerative disorder. Autophagic dysfunction in PD can occur at several stages of the autophagy/lysosom...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x13666151030103027

    authors: Rivero-Ríos P,Madero-Pérez J,Fernández B,Hilfiker S

    更新日期:2016-01-01 00:00:00

  • Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.

    abstract::Neuronal nicotinic acetylcholine receptors (nAChRs) belong to a super-family of Cysloop ligand-gated ion channels that respond to endogenous acetylcholine (ACh) or other cholinergic ligands. These receptors are also the targets of drugs such as nicotine (the main addictive agent delivered by cigarette smoke) and are i...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159X15666170912110450

    authors: Zoli M,Pucci S,Vilella A,Gotti C

    更新日期:2018-01-01 00:00:00

  • Potential effects of cannabidiol as a wake-promoting agent.

    abstract::Over the last decades, the scientific interest in chemistry and pharmacology of cannabinoids has increased. Most attention has focused on ∆(9)-tetrahydrocannabinol (∆(9)-THC) as it is the psychoactive constituent of Cannabis sativa (C. sativa). However, in previous years, the focus of interest in the second plant cons...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X11666131204235805

    authors: Murillo-Rodríguez E,Sarro-Ramírez A,Sánchez D,Mijangos-Moreno S,Tejeda-Padrón A,Poot-Aké A,Guzmán K,Pacheco-Pantoja E,Arias-Carrión O

    更新日期:2014-05-01 00:00:00

  • The Emerging Role of the Double-Edged Impact of Arachidonic Acid- Derived Eicosanoids in the Neuroinflammatory Background of Depression.

    abstract::Eicosanoids are arachidonic acid (AA) derivatives belonging to a family of lipid signalling mediators that are engaged in both physiological and pathological processes in the brain. Recently, their implication in the prolonged inflammatory response has become a focus of particular interest because, in contrast to acut...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X18666200807144530

    authors: Regulska M,Szuster-Głuszczak M,Trojan E,Leśkiewicz M,Basta-Kaim A

    更新日期:2021-01-01 00:00:00

  • The benzydamine experience: a systematic review of benzydamine abuse.

    abstract:BACKGROUND:Both prescription and over-the-counter (OTC) drugs recently emerged among novel psychoactive substances (NPS) being reported as ingested for recreational purposes. Among them, benzydamine (BZY), normally prescribed as an OTC anti-inflammatory drug, is reportedly being diverted and recreationally used. OBJEC...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X19666210113151136

    authors: Stefania C,Andrea M,Alessio M,Mauro P,Amira G,Martin CJ,Giovanni M,Massimo DG,Fabrizio S

    更新日期:2021-01-13 00:00:00

  • May exercise prevent addiction?

    abstract::Amphetamines exert their persistent addictive effects by activating brain's reward pathways, perhaps through the release of dopamine in the nucleus accumbens (and/or in other places). On the other hand, there is a relationship between dopamine and all behavioural aspects that involve motor activity and it has been dem...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015911795017380

    authors: Fontes-Ribeiro CA,Marques E,Pereira FC,Silva AP,Macedo TR

    更新日期:2011-03-01 00:00:00

  • The sigma receptor: evolution of the concept in neuropsychopharmacology.

    abstract::Although originally proposed as a subtype of opioid receptors, the sigma receptor is now confirmed to be a non-opioid receptor that binds diverse classes of psychotropic drugs. Sigma receptors are subdivided into two subtypes, sigma-1 and sigma-2. The sigma-1 receptor is a 25-kDa protein possessing one putative transm...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015905774322516

    authors: Hayashi T,Su T

    更新日期:2005-10-01 00:00:00

  • Neuroprotection: the emerging concept of restorative neural stem cell biology for the treatment of neurodegenerative diseases.

    abstract::During the past decades Neural Stem Cells have been considered as an alternative source of cells to replace lost neurons and NSC transplantation has been indicated as a promising treatment for neurodegenerative disorders. Nevertheless, the current understanding of NSC biology suggests that, far from being mere spare p...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015911795596603

    authors: Carletti B,Piemonte F,Rossi F

    更新日期:2011-06-01 00:00:00

  • REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in Particular.

    abstract::Sleep, an essential physiological process, has been divided into rapid eye movement sleep (REMS) and non-REMS (NREMS) in higher animals. REMS is a unique phenomenon that unlike other sleep-waking states is not under voluntary control. Directly or indirectly it influences or gets influenced by most of the physiological...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x13666150414185737

    authors: Mehta R,Singh A,Bókkon I,Nath Mallick B

    更新日期:2016-01-01 00:00:00

  • Tyrosol as a neuroprotector: strong effects of a "weak" antioxidant.

    abstract::The use of neuroprotective agents for stroke is pathogenetically justified, but the translation of results of preclinical studies of neuroprotectors into clinical practice has been a noticeable failure. One of the leading reasons for these failures is the one-target mechanism of their activity. p-Tyrosol (Tyr), a biop...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X18666200507082311

    authors: Plotnikov MB,Plotnikova TM

    更新日期:2020-05-06 00:00:00

  • Role of Grina/Nmdara1 in the Central Nervous System Diseases.

    abstract::Glutamate receptor, ionotropic, N-methyl-D-aspartate associated protein 1 (GRINA) is a member of the NMDA receptors (NMDARs) and is involved in several neurological diseases, which governs the key processes of neuronal cell death or the release of neurotransmitters. Upregulation of GRINA has been reported in multiple ...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X18666200303104235

    authors: Chen K,Yang LN,Lai C,Liu D,Zhu LQ

    更新日期:2020-01-01 00:00:00

  • Rat Ultrasonic Vocalizations and Behavioral Neuropharmacology: From the Screening of Drugs to the Study of Disease.

    abstract::Several lines of evidence indicate that rats emit ultrasonic vocalizations (USVs) in response to a wide range of stimuli that are capable of producing either euphoric (positive) or dysphoric (negative) emotional states. On these bases, recordings of USVs are extensively used in preclinical studies of affect, motivatio...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x13999150318113800

    authors: Simola N

    更新日期:2015-01-01 00:00:00

  • An Overview of the Heterogeneity of Major Depressive Disorder: Current Knowledge and Future Prospective.

    abstract::Major depressive disorder (MDD) is estimated to impose maximum debilitating effects on the society by 2030, with its critical effects on health, functioning, quality of life and concomitant high levels of morbidity and mortality. Yet, the disease is inadequately understood, diagnosed and treated. Moreover, with the re...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159X17666191001142934

    authors: Athira KV,Bandopadhyay S,Samudrala PK,Naidu VGM,Lahkar M,Chakravarty S

    更新日期:2020-01-01 00:00:00

  • Recent progress of imaging agents for Parkinson's disease.

    abstract::Parkinson's disease (PD) is a common progressive, neurodegenerative brain disease that is promoted by mitochondrial dysfunction, oxidative stress, protein aggregation and proteasome dysfunction in the brain. Compared with computer tomography (CT) or magnetic resonance imaging (MRI), non-invasive nuclear radiopharmaceu...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X13666141204221238

    authors: Wu X,Cai H,Ge R,Li L,Jia Z

    更新日期:2014-12-01 00:00:00

  • Role of wnt signaling in the control of adult hippocampal functioning in health and disease: therapeutic implications.

    abstract::It is well recognized the role of the Wnt pathway in many developmental processes such as neuronal maturation, migration, neuronal connectivity and synaptic formation. Growing evidence is also demonstrating its function in the mature brain where is associated with modulation of axonal remodeling, dendrite outgrowth, s...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X11311050001

    authors: Ortiz-Matamoros A,Salcedo-Tello P,Avila-Muñoz E,Zepeda A,Arias C

    更新日期:2013-09-01 00:00:00

  • Tuning and fine-tuning of synapses with adenosine.

    abstract::The 'omnipresence' of adenosine in all nervous system cells (neurons and glia) together with the intensive release of adenosine following insults, makes adenosine as a sort of 'maestro' of synapses leading to the homeostatic coordination of brain function. Besides direct actions of adenosine on the neurosecretory mech...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015909789152128

    authors: Sebastião AM,Ribeiro JA

    更新日期:2009-09-01 00:00:00

  • Deciphering Subtype-Selective Modulations in TRPA1 Biosensor Channels.

    abstract::The transient receptor potential (TRP) proteins are a family of ion channels that act as cellular sensors. Several members of the TRP family are sensitive to oxidative stress mediators. Among them, TRPA1 is remarkably susceptible to various oxidants, and is known to mediate neuropathic pain and respiratory, vascular a...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x1302150525122020

    authors: Kozai D,Sakaguchi R,Ohwada T,Mori Y

    更新日期:2015-01-01 00:00:00

  • Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.

    abstract::From the initial characterizations of inflammatory responses in Alzheimer's disease (AD) affected brains, namely the demonstration of activated microglia and reactive astrocytes, complement system activation, increased production of proinflammatory cytokines, and evidence for microglial-produced neurotoxins, there was...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015907782793667

    authors: Walker D,Lue LF

    更新日期:2007-12-01 00:00:00

  • Aquaporin biology and nervous system.

    abstract::Our understanding of the movement of water through cell membranes has been greatly advanced by the discovery of a family of water-specific, membrane-channel proteins: the Aquaporins (AQPs). These proteins are present in organisms at all levels of life, and their unique permeability characteristics and distribution in ...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015910791233204

    authors: Buffoli B

    更新日期:2010-06-01 00:00:00

  • Effects of risperidone in autistic children and young adults: A Systematic Review and Meta-Analysis.

    abstract::There are several studies investigating the effects of risperidone in autism, but many of these studies are contradictory or inconclusive. This systematic review and meta-analysis investigated the effects of risperidone on five domains of Aberrant Behaviour Checklist (ABC) scale on Autism Spectrum Disorder (ASD), as w...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X18666200529151741

    authors: Mano-Sousa BJ,Pedrosa AM,Alves BC,Galduróz JCF,Belo VS,Chaves VE,Duarte-Almeida JM

    更新日期:2020-05-29 00:00:00

  • The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies.

    abstract::Long-term potentiation (LTP) and long-term depression (LTD) are two distinct forms of synaptic plasticity that have been extensively characterized at the Schaffer collateral-CA1 (SCCA1) synapse and the mossy fiber (MF)-CA3 synapse within the hippocampus, and are postulated to be the molecular underpinning for several ...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x13666150421003225

    authors: Senter RK,Ghoshal A,Walker AG,Xiang Z,Niswender CM,Conn PJ

    更新日期:2016-01-01 00:00:00